Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT01837056
Brief Summary:
Investigate the prevalence of Toxoplasma gondii and Toxocara canis in Uveitis
* serum antibody to T. gondii and T. canis
* PCR with peripheral blood for T. gondii and T. canis
* PCR with aqueous humor for T. gondii and T. canis
* Clinical manifestation of patient with uveitis
Detailed Description:
Consecutive patients with uveitis are enrolled in Nune Eye Hospital.
Serum ELISA
* IgM,IgG antibody to Toxoplasma gondii
* IgG antibody to Toxocara canis
PCR
* PCR with serum and aqueous humor to Toxoplasma gondii
* PCR with serum and aqueous humor to Toxocara canis Clinical characteristics
* visual acuity
* intraocular pressure (IOP)
* location and degree of inflammation
* other fundus findings were recorded
questionnaire
* environment, occupation
* pet ownership, exposure to animal
* history of eating raw liver of animal, raw beef or any other raw flesh of animal.
Study:
NCT01837056
Study Brief:
Protocol Section:
NCT01837056